These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
128 related items for PubMed ID: 15789915
21. Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves' ophthalmopathy. Aktaran S, Akarsu E, Erbağci I, Araz M, Okumuş S, Kartal M. Int J Clin Pract; 2007 Jan; 61(1):45-51. PubMed ID: 16889639 [Abstract] [Full Text] [Related]
22. Treatment of Graves' hyperthyroidism--prognostic factors for outcome. Alfadda A, Malabu UH, El-Desouki MI, Al-Rubeaan KA, Al-Ruhaily AD, Fouda MA, Al-Maatouq MA, Sulimani RA. Saudi Med J; 2007 Feb; 28(2):225-30. PubMed ID: 17268701 [Abstract] [Full Text] [Related]
23. A treatment strategy for Graves' orbitopathy. Marcocci C, Pinchera A, Marinò M. Nat Clin Pract Endocrinol Metab; 2007 May; 3(5):430-6. PubMed ID: 17452970 [Abstract] [Full Text] [Related]
29. [Combined therapy with cyclosporin A and cortisone in endocrine Basedow endocrine orbitopathy: successful use in compressive optic neuropathy]. Weissel M, Zielinski CC, Hauff W, Till P. Acta Med Austriaca; 1993 May; 20(1-2):9-13. PubMed ID: 8475683 [Abstract] [Full Text] [Related]
30. [Radiation therapy for Graves' ophthalmopathy]. Misaki T. Nihon Rinsho; 2006 Dec; 64(12):2287-90. PubMed ID: 17154093 [Abstract] [Full Text] [Related]
31. [Radiation therapy for thyroid-associated ophthalmopathy]. Luo QL, He WM, Tang L, Chen LJ. Zhonghua Yan Ke Za Zhi; 2006 Mar; 42(3):218-21. PubMed ID: 16643752 [Abstract] [Full Text] [Related]
33. Effect of high-dose intravenous steroid pulse therapy followed by 3-month oral steroid therapy for Graves' ophthalmopathy. Ohtsuka K, Sato A, Kawaguchi S, Hashimoto M, Suzuki Y. Jpn J Ophthalmol; 2002 Feb; 46(5):563-7. PubMed ID: 12457917 [Abstract] [Full Text] [Related]
34. Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit? Dietlein M, Moka D, Reinholz U, Schmidt M, Schomäcker K, Schicha H, Wellner U. Nuklearmedizin; 2007 Feb; 46(3):77-84. PubMed ID: 17549318 [Abstract] [Full Text] [Related]
35. [Graves' orbitopathy]. Balázs C. Orv Hetil; 2006 Jun 04; 147(22):1011-7. PubMed ID: 16913090 [Abstract] [Full Text] [Related]
36. [The cooperation between the ophthalmologist and the endocrinologist in the treatment of the endocrine orbitopathy]. Ferková S, Chynoranský M, Podoba J, Cmelo J. Cesk Slov Oftalmol; 2007 Apr 04; 63(2):108-16. PubMed ID: 17419323 [Abstract] [Full Text] [Related]
37. Long-term results of surgical treatment in Graves' disease orbitopathy. Is there a correlation between the extent of thyroidectomy and the course of orbithopathy? Maurer E, Dănilă R, Dominguez E, Osei-Agymang T, Zielke A, Hassan I. Chirurgia (Bucur); 2008 Apr 04; 103(3):291-5. PubMed ID: 18717277 [Abstract] [Full Text] [Related]
38. [Graves' ophthalmopathy: diagnosis and highlights on etiopathogenesis and treatment]. Kamoun M, Abid H, Lamine F, Slimane H, Haddad A. Tunis Med; 2003 Mar 04; 81(3):149-55. PubMed ID: 12793063 [Abstract] [Full Text] [Related]
39. [Orbital-bony decompression in patients with dysthyroid orbitopathy--first Croatian experiences]. Juri J, Stiglmayer N, Kuzman T. Acta Med Croatica; 2006 Mar 04; 60(2):83-6. PubMed ID: 16848193 [Abstract] [Full Text] [Related]
40. The effect of methylprednisolone pulse treatment on cytokine network in Graves ophthalmopathy. Lacka K, Manuszewska E, Korczowska I, Lacki JK. Curr Eye Res; 2007 Mar 04; 32(3):291-7. PubMed ID: 17453949 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]